EN DE
Watch Polygiene AB for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Polygiene AB (POLYG) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of Polygiene AB stock SEK 2.22, price SEK 2.60, that is 14.6% below the price, quality 42 out of 100. Rating: overvalued. Calculated from audited financials with 6 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Basic Materials SE · ISIN SE0007692157

PA Polygiene AB logo Thin data Nov 9, 2026

Polygiene AB

POLYG · ST
Expensive, weak quality

Our calculation puts a fair price 15% below what the stock costs today.

Low debt
Quality 42/100
Revenue last quarter 28% below a year ago.
Fair value kr 2.22 · Overvalued
Weak Growth (revenue 3y −5.5 %/yr in SEK)
Loss-making · -7.7% net margin (TTM)
Negative free cash flow
Trails peers (4/11)
Narrow moat 12/100 · thin data
Thin data
⟳ Cyclical
Watch Polygiene AB for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

kr 51.47 kr 2.21 Fair Value kr 2.22 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 9, 2026.

How to read this chart

60‑month range kr 2.21 – kr 51.47 · fair‑value band kr 2.20 – kr 2.22 · the kr 2.60 price screens above the kr 2.22 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 2 fiscal years are left out: there the valuation rested on only a fraction of the usual models. As of Nov 9, 2026.

Follow Polygiene in your weekly email

Every Wednesday you see whether Polygiene is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Polygiene Group AB provides antimicrobial technologies for textiles and other hard surfaces in the Asia Pacific, Europe, the Middle East, Africa, the United States, and internationally. It operates through two segments: Polygiene and Addmaster.

Show moreShow less

The company offers antimicrobial, anti-viral, and odor control solutions, including OdorCrunch, StayFresh, ScentMaster, ViralOff, BioMaster, and VeriMaster under the Polygiene brand.

It serves partners across various categories, such as sports and outdoors, fashion and lifestyle, workwear, hospitality, home and pets, healthcare, water, industrial, and paper and packaging.

The company was formerly known as Polygiene AB (publ.) and changed its name to Polygiene Group AB in June 2022. Polygiene Group AB was founded in 2005 and is headquartered in Malmö, Sweden.

Stock analysis

Polygiene AB (POLYG) currently trades at kr 2.60, while our model-based Fair Value estimate is kr 2.22, 15% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Asset-Based group reads highest at a median of kr 2.08 per share, and 0 of the 6 models we run sit above the kr 2.60 price.

Bear case: the Multiples group reads lowest at kr 1.08, and 6 of the 6 models stay below the price. Data coverage for this calculation is low.

Scenario range: kr 2.20 (bear) to kr 2.22 (bull), the price of kr 2.60 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 42/100 (below-average quality), in the Basic Materials sector.

Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

Polygiene AB reported revenue of 147M SEK in FY2025 versus 182M SEK in FY2021, a compound −5.2%/yr. Reported net income was −5.6M SEK in FY2025.

Key figures

Market cap 97.2M SEK (≈ $9.8M) Micro · P/S ratio 0.69 · EPS (TTM) kr −0.2700 · Net margin −7.7% · Return on equity −3.3% · Return on assets (EBIT) −17.2% (5-year average) · Operating margin −13.5% · Revenue (TTM) 126M SEK.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 12 out of 100 (low confidence).

What moves the price

The share trades about 75% below its 52-week high and 18% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Basic Materials peers we cover trades at −43% fair-value upside, at −15%, POLYG screens cheaper than that median.

Fair Value models

Bear kr 2.20 Fair Value kr 2.22 Bull kr 2.22
Price kr 2.60 · Downside -14.6%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
EPV kr 1.10 kr 1.11 kr 1.11 74
ROIC Compounder kr 1.10 kr 1.11 kr 1.11 70
EV/EBITDA kr 2.16 kr 2.57 kr 2.98 67
All 6 models by family
Earnings-Based
EPV kr 1.10 kr 1.11 kr 1.11 74
Multiples
EV/EBIT kr 1.04 kr 1.08 kr 1.11 66
EV/EBITDA kr 2.16 kr 2.57 kr 2.98 67
EV/Revenue kr 1.03 kr 1.07 kr 1.10 54
Asset-Based
NCAV (Graham) kr 1.38 kr 2.08 kr 2.60 55
Economic Profit
ROIC Compounder kr 1.10 kr 1.11 kr 1.11 70

The fair value above starts from this blend and is adjusted for a cyclical trough year.

Open the full fair value analysis →

Quality Score breakdown

Overall quality 42/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 16
How much profit the company makes from its sales and capital
Quality Growth 13
Are margins and returns getting better?
Cashflow 28
Do the profits arrive as real cash?
Financial strength 55
Debt, balance sheet and risk of trouble
Investment 100
Does it invest with discipline instead of growing at any price?
Low Volatility 6
How calm the share price moves, does not count
Price momentum 0
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 3
Distance to the 52-week high, does not count
New shares 66
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 33/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
−6.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−5.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+11.8%
Start year 2020 (pandemic). Over 10 years: +11.0% a year
Revenue growth 13 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+17.2%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
0.1% (2020) → 0.2% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

POLYG screens overvalued: fair value 15% below the price. Compare with Linde plc →

Compare Polygiene AB with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 728 stocks

Beats the industry median on 3/9 measures
Overall it trails its industry peers.
Valuation
Quality Score 42 · Bottom 25%
Fair Value upside −14.6% · Above median
Profitability
Return on assets −1.8% · Bottom 25%
Net margin (12 months) −7.7% · Bottom 25%
Operating margin (12 months) −13.5% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) −27.6% · Bottom 25%
Dividend yield (12 months) 0.0% · Bottom 25%

Valuation Multiplesvs Specialty Chemicals median · lower = cheaper

P/B 0.35× · Cheapest 25%
P/S (12 months) 0.77× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)14 · sector 0
FUTURE (revenue growth)0 · sector 67
PAST (return on equity)0 · sector 27
HEALTH (low debt)100 · sector 95
DIVIDEND (yield)0 · sector 31

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Nan Ya Plastics Corporation 1303 263.00 TWD 420.80 TWD +60% vs POLYG
Wanhua Chemical Group 600309 ¥72.65 ¥68.03 −6% vs POLYG
Linde plc LIN $515.25 $446.62 −13% vs POLYG
PPG Industries, Inc PPG $122.38 $77.68 −37% vs POLYG
DSM-Firmenich AG DSFIR CHF 100.50 CHF 57.70 −43% vs POLYG
The Sherwin-Williams Company SHW $344.10 $146.37 −57% vs POLYG
Givaudan SA GIVN CHF 4,054 CHF 1,554 −62% vs POLYG
EMS-CHEMIE HOLDING AG EMSN CHF 848.50 CHF 284.63 −66% vs POLYG
Ecolab Inc ECL $300.68 $96.56 −68% vs POLYG
Air Products and Chemicals, Inc APD $304.84 $75.33 −75% vs POLYG

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Polygiene AB: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Polygiene AB Fair Value". https://www.fairvalue-calculator.com/stock/POLYG

Frequently asked questions

Is Polygiene AB (POLYG) overvalued or undervalued?
As of Nov 9, 2026, our model estimates a fair value of kr 2.22 versus a price of kr 2.60, about 15% lower (overvalued).
What is the fair value of POLYG?
Our model-based fair value for Polygiene AB is kr 2.22 (as of Nov 9, 2026), built from audited fundamentals. The current price: kr 2.60.
What is the quality score of POLYG?
Polygiene AB has a Quality Score of 42/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Polygiene AB (POLYG)?
Our model-based price target is the fair value of kr 2.22 (as of Nov 9, 2026) from 6 valuation models. Cautious scenario kr 2.20, optimistic scenario kr 2.22. It is a calculation from audited fundamentals, not an analyst target.
What is the Polygiene AB stock forecast for 2026?
Our models put fair value at kr 2.22, about 15% lower versus a price of kr 2.60 (overvalued). Cautious scenario kr 2.20, optimistic scenario kr 2.22. The calculation is refreshed regularly with new filings.
What is the revenue of Polygiene AB (POLYG)?
Polygiene AB reported trailing-twelve-month revenue of about 126M SEK (latest available figure, as of Nov 9, 2026).
What is the intrinsic value of Polygiene AB (POLYG)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Polygiene AB it is kr 2.22 per share (as of Nov 9, 2026), against a price of kr 2.60. It is the blended result of 6 valuation models in 4 families (Earnings-Based, Multiples, Asset-Based, Economic Profit).
Is Polygiene AB stock overvalued or undervalued in 2026?
As of Nov 9, 2026, POLYG trades above its calculated fair value: price kr 2.60, fair value kr 2.22, a gap of about −15% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of POLYG?
No. The price is what the market pays today (kr 2.60); the fair value is what the company's own numbers justify (kr 2.22). For Polygiene AB the two are kr 0.3800 per share apart. That gap is exactly why we show both numbers side by side.
How much is Polygiene AB worth?
The market values Polygiene AB at about 97.2M SEK (market capitalisation, as of Nov 9, 2026). Per share that is kr 2.60; our models calculate a fair value of kr 2.22 per share.
What do the bullish and bearish scenarios say about POLYG?
Our models span a range for Polygiene AB: cautious scenario kr 2.20, base kr 2.22, optimistic kr 2.22 per share (as of Nov 9, 2026, price kr 2.60). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Polygiene AB (POLYG)?
Balance-sheet figures for Polygiene AB (as of Nov 9, 2026): return on equity −3.3%. They feed the Quality Score of 42/100, which measures business quality independently of the share price.
How far is POLYG from its 52-week high?
Polygiene AB trades at kr 2.60, about 75% below its 52-week high of kr 10.25 and 18% above the low of kr 2.21 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of kr 2.22 is for.
Which stocks are comparable to Polygiene AB?
From the same area (Basic Materials) we also value Linde plc, Ecolab Inc, The Sherwin-Williams Company, Nan Ya Plastics Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Polygiene AB stock attractive at the current price?
The data as of Nov 9, 2026: price kr 2.60, calculated fair value kr 2.22 (−15%), Quality Score 42/100, from 6 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of POLYG calculated?
We run Polygiene AB through 6 models from 4 families: Earnings-Based, Multiples, Asset-Based, Economic Profit. Every model gets the same audited fundamentals; the fair value of kr 2.22 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Polygiene AB itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Polygiene AB (POLYG)?
The closing price on Nov 6, 2026 was kr 2.60. Our model-based fair value is kr 2.22, about 15% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Polygiene AB right now?
The price sits above even our optimistic bull case (kr 2.22). The favourable scenario is already priced in. The models converge in a tight band (kr 2.20 to kr 2.22), unusually little disagreement for a valuation. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Polygiene AB

How large is the market capitalisation of Polygiene AB (POLYG)?
The market capitalisation of Polygiene AB is 97.2M SEK (≈ $9.8M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Polygiene AB (POLYG)?
The price-to-sales ratio of Polygiene AB is 0.69 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Polygiene AB (POLYG)?
Earnings per share at Polygiene AB are kr −0.2700. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Polygiene AB (POLYG)?
The net margin of Polygiene AB is −7.7% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Polygiene AB (POLYG)?
The return on equity (ROE) of Polygiene AB is −3.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Polygiene AB (POLYG)?
On an EBIT basis the return on assets of Polygiene AB is −17.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Polygiene AB (POLYG)?
The operating margin of Polygiene AB is −13.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Polygiene AB (POLYG)?
Revenue at Polygiene AB is growing −27.6% versus a year earlier (3y avg −5.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Polygiene AB (POLYG)?
Earnings per share at Polygiene AB are growing +100% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Polygiene AB (POLYG) generate?
The free cash flow of Polygiene AB is −11.0M SEK (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Polygiene AB (POLYG) hold?
Polygiene AB holds more cash than debt, 34.2M SEK net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Polygiene AB in the live analysis

One click puts Polygiene AB on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.